265 related articles for article (PubMed ID: 28137987)
1. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique.
Ukah UV; Mbofana F; Rocha BM; Loquiha O; Mudenyanga C; Usta M; Urso M; Drebit S; Magee LA; von Dadelszen P
Hypertension; 2017 Mar; 69(3):469-474. PubMed ID: 28137987
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis of preeclampsia using placental growth factor: An operational pilot study in Maputo, Mozambique.
Manriquez Rocha B; Mbofana F; Loquiha O; Mudenyanga C; Ukah UV; Magee LA; von Dadelszen P
Pregnancy Hypertens; 2018 Jan; 11():26-31. PubMed ID: 29523269
[TBL] [Abstract][Full Text] [Related]
3. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
[TBL] [Abstract][Full Text] [Related]
4. Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study.
Barton JR; Woelkers DA; Newman RB; Combs CA; How HY; Boggess KA; Martin JN; Kupfer K; Sibai BM;
Am J Obstet Gynecol; 2020 Mar; 222(3):259.e1-259.e11. PubMed ID: 31518550
[TBL] [Abstract][Full Text] [Related]
5. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
Duhig KE; Myers J; Seed PT; Sparkes J; Lowe J; Hunter RM; Shennan AH; Chappell LC;
Lancet; 2019 May; 393(10183):1807-1818. PubMed ID: 30948284
[TBL] [Abstract][Full Text] [Related]
6. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
[TBL] [Abstract][Full Text] [Related]
7. PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction.
Cetin I; Mazzocco MI; Giardini V; Cardellicchio M; Calabrese S; Algeri P; Martinelli A; Todyrenchuk L; Vergani P
J Matern Fetal Neonatal Med; 2017 Jan; 30(2):144-149. PubMed ID: 27028483
[TBL] [Abstract][Full Text] [Related]
8. Placental growth factor measurements in the assessment of women with suspected Preeclampsia: A stratified analysis of the PARROT trial.
Duhig KE; Myers JE; Gale C; Girling JC; Harding K; Sharp A; Simpson NAB; Tuffnell D; Seed PT; Shennan AH; Chappell LC
Pregnancy Hypertens; 2021 Mar; 23():41-47. PubMed ID: 33221705
[TBL] [Abstract][Full Text] [Related]
9. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
[TBL] [Abstract][Full Text] [Related]
10. Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.
Sharp A; Chappell LC; Dekker G; Pelletier S; Garnier Y; Zeren O; Hillerer KM; Fischer T; Seed PT; Turner M; Shennan AH; Alfirevic Z
Pregnancy Hypertens; 2018 Oct; 14():228-233. PubMed ID: 29627351
[TBL] [Abstract][Full Text] [Related]
11. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
14. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
[TBL] [Abstract][Full Text] [Related]
15. Importance of Timing First-Trimester Placental Growth Factor and Use of Serial First-Trimester Placental Growth Factor Measurements in Screening for Preeclampsia.
Mosimann B; Amylidi-Mohr S; Höland K; Surbek D; Risch L; Raio L
Fetal Diagn Ther; 2017; 42(2):111-116. PubMed ID: 28199996
[TBL] [Abstract][Full Text] [Related]
16. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
[TBL] [Abstract][Full Text] [Related]
17. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
18. An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome.
Hoffmann J; Ossada V; Weber M; Stepan H
Pregnancy Hypertens; 2017 Oct; 10():165-170. PubMed ID: 29153672
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of repeat placental growth factor measurements in women with suspected preeclampsia: A case series study.
Duhig KE; Webster LM; Sharp A; Gill C; Seed PT; Shennan AH; Myers JE; Chappell LC
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):994-1002. PubMed ID: 32017014
[TBL] [Abstract][Full Text] [Related]
20. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction.
Sibiude J; Guibourdenche J; Dionne MD; Le Ray C; Anselem O; Serreau R; Goffinet F; Tsatsaris V
PLoS One; 2012; 7(11):e50208. PubMed ID: 23209675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
